Navigation Links
Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
Date:2/1/2011

EXTON, Pa., Feb. 1, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its second quarter ended December 31, 2010.  

Second Quarter Snapshot and Recent Developments

  • Diluted EPS of $0.38, in line with the Company's previous guidance of $0.37-$0.40, and representing an increase from the prior year comparable quarter's diluted EPS of $0.32 and a decrease from the prior year comparable quarter's adjusted diluted EPS*of $0.43.
  • Revenue of $17.4 million, in line with the Company's previous guidance of $17.0-$17.8 million and representing a decrease from the prior year comparable quarter's revenue of $19.1 million.
  • Net sales of $10.9 million, in line with the Company's previous guidance of $10.3-$11.0 million and representing a decrease from the prior year comparable quarter's net sales of $12.5 million.
  • Royalty income of $6.5 million, below the Company's previous guidance of $6.7-$6.8 million and representing a decrease from the prior year comparable quarter's royalty income of $6.6 million.
  • Operating margin of 29%.
  • Cash from operations of $2.2 million in the quarter.
  • EBITDA* of $6.8 million.
  • Entered into a manufacturing agreement with, and made a minority equity investment in, Orteq Sports Medicine, a medical device company specializing in the field of biodegradable polymer technology for meniscus repair.
  • Signed distribution agreement with Arthrex, Inc. for the European distribution of the Company's Cartilage Repair Device.
  • Acquired the net assets of Nerites Corporation, a developer of medical adhesives and anti-fouling coatings (See the Company's January 31, 2011 press release).

  • President and CEO Commentary "Although our secon
    '/>"/>

    SOURCE Kensey Nash Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
    2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
    3. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
    4. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
    5. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
    6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    8. Par Pharmaceutical Reports Second Quarter 2008 Results
    9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    10. Pharmos Corporation Reports 2008 Second Quarter Results
    11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... Cheshire Cat: Can a particle be separated from its ... Communications , published the results of the first Cheshire ... conducted by Chapman University in Orange, CA, and Vienna ... a cat without a grin," thought Alice in Wonderland, ... curious thing I ever saw in my life!" Alice,s ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 Second generation biofuels ... imposed by fossil fuels. However, as natural gas is very ... as they are not as valuable as they could be ... the difficulty financing projects, has made it difficult for renewable ... projects get off the ground. For these reasons, certain companies ...
    (Date:7/29/2014)... , July 29, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, applauds ... for taking a strong position in opposition to ... July 27, 2014 publication.  The New York Times ... articles this week exploring the issue called "High ...
    (Date:7/29/2014)... Genera Energy Inc. , a ... supply chain advancements, has announced the deployment of ... and Supply ASSURE™. Both systems were developed ... at consolidating and simplifying the entire process, managing ... feedstock end users. , “Through the Energy Grange ...
    Breaking Biology Technology:The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4
    ... Bioscience announced today that it will be participating in ... The conference will be held at the Frontier Airlines ... August 3, 2011. Roka will be located at booth ... introduce a novel molecular instrument platform for the detection ...
    ... -   Text-to-speech application enables researchers to listen ...  Elsevier, a world leading provider of scientific, technical ... of an audio reader application from iSpeech, provider of cloud-based ... . The iSpeech Audio Reader is the latest in a ...
    ... 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... completed the randomized portion of its Phase 3 clinical ... for the treatment of moderate to severe chronic pain, ... "We are very pleased to have brought ...
    Cached Biology Technology:iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 3iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 4BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 2BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 3
    (Date:7/28/2014)... 100 drugs already approved by the U.S. Food and ... the growth of certain bacterial pathogens inside human cells, ... spotted fever. The findings, published in mBio , ... Microbiology, demonstrate a new way of identifying non-antibiotic drugs ... , A handful of drugs on the list inhibit ...
    (Date:7/28/2014)... and organic compounds in hydrothermal environments are critical components ... for the deep biosphere, and may have implications for ... about how minerals influence organic reactions. A team ... a common mineral acts as a catalysts for specific ... solvents or expensive reagents. , At the heart of ...
    (Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
    Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3
    ... analysis, carbon dioxide removal could be used under certain ... but it would not replace the bulk of actual ... allows to separate emissions control from the time and ... important for climate protection," says lead-author Elmar Kriegler. "You ...
    ... Stem cells can be coaxed to grow into new ... the right molecular cues and room inside a water-loving ... By creating a three-dimensional checkerboardone with alternating highly connected ... adjusting the size of the micropattern could affect stem ...
    ... of Houston chemical and biomolecular engineering professor,s theories on ... Station (ISS). Professor Peter Vekilov received a grant ... solution nucleate, or form crystals. While researchers understand how ... they transform from liquid to crystal. Vekilov discovered ...
    Cached Biology News:CO2 removal can lower costs of climate protection 2CO2 removal can lower costs of climate protection 3Stem cell proliferation and differentiation observed within hydrogel 2University of Houston engineering researcher's theories to be tested in space 2
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    Use our experts and resources to develop reagent systems for your applications....
    Biology Products: